full-length Factor VIII molecule (Bayer Schering Pharma)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namefull-length Factor VIII molecule (Bayer Schering Pharma)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionCoagulation factor VIII stimulants
TargetsCoagulation factor VIII
Therapy Area/IndicationsHemophilia A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer Schering Pharma AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer Schering Pharma AG
Active IndicationsN/A
Inactive IndicationsHemophilia A

Other Information

ATC CodeN/A
Related LinksN/A